NDC11 51759034750
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51759-0347-50 | 51759-0347 |
| 51759-347-50 | 51759-347 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| WELTRUZA | OLANZAPINE | Teva Pharmaceuticals USA, Inc. | a23e99c7-fb76-46d2-95af-e03d5a4d1f2c | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 51759-347-50 51759-347 51759034750 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.